Solvents and solubilizers in product development MCQs With Answer

Solvents and solubilizers are fundamental in drug product development, affecting solubility, stability, bioavailability, and manufacturability for B. Pharm students. This introduction highlights solvents, co‑solvents, surfactants, cyclodextrins, micellar solubilization, pH adjustment, solid dispersions, and SEDDS, plus physicochemical concepts such as polarity, dielectric constant, Hildebrand and Hansen solubility parameters. Practical topics include solvent classification, miscibility, volatility, handling, toxicity and ICH residual solvent limits, along with surfactant HLB and formulation strategies. You will also explore mechanisms — complexation, co‑solvency, micellar incorporation, and amorphization — and regulatory and scale‑up considerations. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. What is the primary role of a solvent in pharmaceutical formulation?

• React chemically with the drug to form derivatives
• Dissolve solutes to create a homogeneous medium
• Serve as the final active pharmaceutical ingredient
• Reduce the pH of all formulations

Correct Answer: Dissolve solutes to create a homogeneous medium

Q2. Which of the following best defines a solubilizer?

• A compound that always crystallizes a drug
• An agent that increases the apparent solubility of poorly soluble drugs
• A preservative used to extend shelf life
• A buffer that fixes pH at 7.4

Correct Answer: An agent that increases the apparent solubility of poorly soluble drugs

Q3. The Hildebrand solubility parameter is most directly related to which property?

• Dielectric constant of a solvent
• Cohesive energy density and solute–solvent compatibility
• Viscosity at 25°C
• Surfactant hydrophilic–lipophilic balance

Correct Answer: Cohesive energy density and solute–solvent compatibility

Q4. Hansen solubility parameters separate cohesive interactions into which three components?

• Hydrophobic, ionic, and metallic
• Dispersive, polar, and hydrogen-bonding
• Viscous, elastic, and plastic
• Acidic, basic, and neutral

Correct Answer: Dispersive, polar, and hydrogen-bonding

Q5. Which statement correctly distinguishes protic from aprotic solvents?

• Protic solvents cannot hydrogen-bond; aprotic solvents always form hydrogen bonds
• Protic solvents can donate hydrogen bonds; aprotic solvents cannot donate hydrogen bonds
• Aprotic solvents are always nonpolar; protic solvents are always ionic
• There is no difference in hydrogen-bonding capability

Correct Answer: Protic solvents can donate hydrogen bonds; aprotic solvents cannot donate hydrogen bonds

Q6. A solvent with a high dielectric constant is generally:

• Nonpolar and lipophilic
• Highly polar and good at stabilizing ionic species
• Always volatile and low boiling
• Incapable of dissolving salts

Correct Answer: Highly polar and good at stabilizing ionic species

Q7. How does co‑solvent addition typically increase solubility of a lipophilic drug?

• By crystallizing the drug into a less soluble polymorph
• By reducing the overall polarity of the solvent environment and increasing drug solvation
• By increasing the ionic strength to precipitate the drug
• By hydrolyzing the drug into smaller fragments

Correct Answer: By reducing the overall polarity of the solvent environment and increasing drug solvation

Q8. Which of the following are commonly used pharmaceutical co‑solvents?

• Benzene, carbon tetrachloride, chloroform
• Ethanol, propylene glycol, polyethylene glycol 400
• Mercury, lead acetate, toluene
• Ammonia, sodium hydroxide, sulfuric acid

Correct Answer: Ethanol, propylene glycol, polyethylene glycol 400

Q9. Micellar solubilization occurs when surfactant concentration exceeds:

• Critical vapor pressure
• Critical micelle concentration (CMC)
• Hansen parameter
• Partition coefficient

Correct Answer: Critical micelle concentration (CMC)

Q10. Which mechanisms commonly contribute to enhanced drug solubility in formulations?

• Micellar incorporation, complexation, co‑solvency, and pH adjustment
• Oxidative degradation, polymerization, and photolysis
• Metal chelation, thermal decomposition, and crystallization
• Electroplating, fermentation, and sublimation

Correct Answer: Micellar incorporation, complexation, co‑solvency, and pH adjustment

Q11. Cyclodextrins improve solubility primarily by:

• Forming covalent bonds with the drug
• Inclusion complexation of hydrophobic moieties inside the cyclodextrin cavity
• Acting as strong acids to protonate drugs
• Buffering the formulation at neutral pH

Correct Answer: Inclusion complexation of hydrophobic moieties inside the cyclodextrin cavity

Q12. According to ICH Q3C, Class 1 residual solvents are:

• Preferred and recommended for use in all formulations
• Solvents to be avoided due to toxicity and environmental risk
• Non-toxic and exempt from control
• Only used in topical products

Correct Answer: Solvents to be avoided due to toxicity and environmental risk

Q13. Which factor is NOT a typical criterion in solvent selection for formulation development?

• Solvent ability to dissolve the drug
• Toxicity and regulatory acceptance
• Boiling point and ease of removal
• Color of the solvent under UV light

Correct Answer: Color of the solvent under UV light

Q14. A surfactant with a high HLB value (>10) is most suitable for forming which type of emulsion?

• Water-in-oil (w/o) emulsion
• Oil-in-water (o/w) emulsion
• Suspendable solid dispersions only
• Non-emulsifying solvents

Correct Answer: Oil-in-water (o/w) emulsion

Q15. Self‑emulsifying drug delivery systems (SEDDS) are best described as:

• Solid salts of drugs used for inhalation
• Anhydrous mixtures of oil, surfactant and co‑solvent that form fine emulsions on dilution
• Pure aqueous solutions with no organic content
• Covalent conjugates of drug and polymer

Correct Answer: Anhydrous mixtures of oil, surfactant and co‑solvent that form fine emulsions on dilution

Q16. Which property distinguishes microemulsions from conventional emulsions?

• Microemulsions are thermodynamically unstable and cloudy
• Microemulsions are thermodynamically stable and often transparent
• Microemulsions contain no surfactant
• Microemulsions always have larger droplet sizes

Correct Answer: Microemulsions are thermodynamically stable and often transparent

Q17. Solid dispersions enhance apparent solubility primarily through:

• Conversion of drug to an amorphous or reduced-crystallinity state and improved wettability
• Increasing particle size and crystallinity
• Converting drug into metallic form
• Reducing the pH to extremely acidic values

Correct Answer: Conversion of drug to an amorphous or reduced-crystallinity state and improved wettability

Q18. For a weakly acidic drug, which pH adjustment generally increases aqueous solubility?

• Lowering pH to more acidic values to favor unionized form
• Raising pH to deprotonate the acid and form soluble anion
• Keeping pH unchanged always gives maximum solubility
• Adding strong oxidizing agents

Correct Answer: Raising pH to deprotonate the acid and form soluble anion

Q19. The partition coefficient (log P) is a measure of:

• Drug’s stability in acidic media
• Drug lipophilicity between octanol and water phases
• Surfactant’s CMC
• Solvent’s dielectric constant

Correct Answer: Drug lipophilicity between octanol and water phases

Q20. Which solvent has the highest dielectric constant at room temperature among these options?

• Chloroform
• Acetone
• Ethanol
• Water

Correct Answer: Water

Q21. An azeotrope is best described as:

• A solid mixture with infinite solubility
• A liquid mixture that boils at constant composition and cannot be separated by simple distillation
• A gas mixture with uniform reactivity
• A type of micelle formed in polar solvents

Correct Answer: A liquid mixture that boils at constant composition and cannot be separated by simple distillation

Q22. Solvatochromic parameters like π* primarily measure:

• Optical rotation of chiral drugs
• Polarity/polarizability of solvents
• Solvent viscosity at different temperatures
• Surfactant molecular weight

Correct Answer: Polarity/polarizability of solvents

Q23. A solvent that is a good hydrogen-bond acceptor but poor donor is typically called:

• Amphoteric solvent
• Hydrogen-bond basic (HBA) solvent
• Hydrogen-bond acidic solvent
• Non-coordinating solvent

Correct Answer: Hydrogen-bond basic (HBA) solvent

Q24. Use of non‑aqueous solvents in parenteral products is limited mainly due to:

• Color incompatibility with plastics
• Solvent toxicity and regulatory restrictions
• Inability to dissolve hydrophobic drugs
• Excessively low boiling points only

Correct Answer: Solvent toxicity and regulatory restrictions

Q25. Which formulation strategy reduces particle size to increase dissolution rate and apparent solubility?

• Particle size reduction (micronization, nanonization)
• Adding insoluble fillers
• Increasing tablet compression force to harden particles
• Lyophilizing the solvent away without controlling morphology

Correct Answer: Particle size reduction (micronization, nanonization)

Q26. For most crystalline drugs, solubility in a given solvent typically changes with temperature in which way?

• Solubility decreases as temperature increases for all drugs
• Solubility increases with temperature for many drugs due to increased molecular motion
• Solubility is independent of temperature
• Solubility becomes zero at higher temperatures

Correct Answer: Solubility increases with temperature for many drugs due to increased molecular motion

Q27. Which factors influence the critical micelle concentration (CMC) of a surfactant?

• Surfactant structure, temperature, ionic strength, and solvent composition
• Only the pH of the solution
• Color and odor of the surfactant
• Presence of metal catalysts exclusively

Correct Answer: Surfactant structure, temperature, ionic strength, and solvent composition

Q28. Polyethylene glycol (PEG 400) is frequently used in formulations because it:

• Is a volatile solvent with high vapor pressure
• Acts as a co‑solvent and viscosity modifier and improves solubility of many drugs
• Always crystallizes active ingredients
• Neutralizes acids and bases covalently

Correct Answer: Acts as a co‑solvent and viscosity modifier and improves solubility of many drugs

Q29. The Yalkowsky log‑linear model for co‑solvency predicts that:

• Solubility is independent of co‑solvent fraction
• The logarithm of solubility often changes nearly linearly with co‑solvent volume fraction
• Solubility decreases exponentially with increased co‑solvent
• Solubility is only determined by pH

Correct Answer: The logarithm of solubility often changes nearly linearly with co‑solvent volume fraction

Q30. Which set of criteria best summarizes practical solvent selection for formulation and scale‑up?

• Color, taste, and magnetic susceptibility
• Solubility performance, safety/toxicity, volatility and ease of removal, cost and regulatory acceptability
• Ability to react irreversibly with the active and form salts
• Exclusively the solvent’s boiling point regardless of toxicity

Correct Answer: Solubility performance, safety/toxicity, volatility and ease of removal, cost and regulatory acceptability

Download